• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Animal Biological Vaccine Market Insights, Forecast to 2026

report cover
  • 22 June 2020
  • Healthcare
  • 146 Pages
  • Report Code: 24LS-8483
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Animal Biological Vaccine -MARKET ADVISORY SERVICES

Animal Biological Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Animal Biological Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Animal Biological Vaccine market is segmented into
Oral
Subcutaneous
Intramuscular
Others

Segment by Application, the Animal Biological Vaccine market is segmented into
Porcine
Poultry
Livestock
Companion Animals
Aquaculture

Regional and Country-level Analysis
The Animal Biological Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Animal Biological Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Animal Biological Vaccine Market Share Analysis
Animal Biological Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Biological Vaccine business, the date to enter into the Animal Biological Vaccine market, Animal Biological Vaccine product introduction, recent developments, etc.
The major vendors covered:
Merck
Zoetis
Merial/Sanofi
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
1 Study Coverage
1.1 Animal Biological Vaccine Product Introduction
1.2 Market Segments
1.3 Key Animal Biological Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Animal Biological Vaccine Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Subcutaneous
1.4.4 Intramuscular
1.4.5 Others
1.5 Market by Application
1.5.1 Global Animal Biological Vaccine Market Size Growth Rate by Application
1.5.2 Porcine
1.5.3 Poultry
1.5.4 Livestock
1.5.5 Companion Animals
1.5.6 Aquaculture
1.6 Coronavirus Disease 2019 (Covid-19): Animal Biological Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Animal Biological Vaccine Industry
1.6.1.1 Animal Biological Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Animal Biological Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Animal Biological Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Animal Biological Vaccine Market Size Estimates and Forecasts
2.1.1 Global Animal Biological Vaccine Revenue 2015-2026
2.1.2 Global Animal Biological Vaccine Sales 2015-2026
2.2 Animal Biological Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Animal Biological Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Animal Biological Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Animal Biological Vaccine Competitor Landscape by Players
3.1 Animal Biological Vaccine Sales by Manufacturers
3.1.1 Animal Biological Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Animal Biological Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Animal Biological Vaccine Revenue by Manufacturers
3.2.1 Animal Biological Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Animal Biological Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Animal Biological Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Animal Biological Vaccine Revenue in 2019
3.2.5 Global Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Animal Biological Vaccine Price by Manufacturers
3.4 Animal Biological Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Animal Biological Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Animal Biological Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Animal Biological Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Animal Biological Vaccine Market Size by Type (2015-2020)
4.1.1 Global Animal Biological Vaccine Sales by Type (2015-2020)
4.1.2 Global Animal Biological Vaccine Revenue by Type (2015-2020)
4.1.3 Animal Biological Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Animal Biological Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Animal Biological Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Animal Biological Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Animal Biological Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Animal Biological Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
5.1 Global Animal Biological Vaccine Market Size by Application (2015-2020)
5.1.1 Global Animal Biological Vaccine Sales by Application (2015-2020)
5.1.2 Global Animal Biological Vaccine Revenue by Application (2015-2020)
5.1.3 Animal Biological Vaccine Price by Application (2015-2020)
5.2 Animal Biological Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Animal Biological Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Animal Biological Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Animal Biological Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Animal Biological Vaccine by Country
6.1.1 North America Animal Biological Vaccine Sales by Country
6.1.2 North America Animal Biological Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Animal Biological Vaccine Market Facts & Figures by Type
6.3 North America Animal Biological Vaccine Market Facts & Figures by Application

7 Europe
7.1 Europe Animal Biological Vaccine by Country
7.1.1 Europe Animal Biological Vaccine Sales by Country
7.1.2 Europe Animal Biological Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Animal Biological Vaccine Market Facts & Figures by Type
7.3 Europe Animal Biological Vaccine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Animal Biological Vaccine by Region
8.1.1 Asia Pacific Animal Biological Vaccine Sales by Region
8.1.2 Asia Pacific Animal Biological Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Animal Biological Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Animal Biological Vaccine Market Facts & Figures by Application

9 Latin America
9.1 Latin America Animal Biological Vaccine by Country
9.1.1 Latin America Animal Biological Vaccine Sales by Country
9.1.2 Latin America Animal Biological Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Animal Biological Vaccine Market Facts & Figures by Type
9.3 Central & South America Animal Biological Vaccine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Animal Biological Vaccine by Country
10.1.1 Middle East and Africa Animal Biological Vaccine Sales by Country
10.1.2 Middle East and Africa Animal Biological Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Animal Biological Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Animal Biological Vaccine Market Facts & Figures by Application

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Animal Biological Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Description, Business Overview and Total Revenue
11.2.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Zoetis Animal Biological Vaccine Products Offered
11.2.5 Zoetis Recent Development
11.3 Merial/Sanofi
11.3.1 Merial/Sanofi Corporation Information
11.3.2 Merial/Sanofi Description, Business Overview and Total Revenue
11.3.3 Merial/Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merial/Sanofi Animal Biological Vaccine Products Offered
11.3.5 Merial/Sanofi Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim Animal Biological Vaccine Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 Ceva
11.5.1 Ceva Corporation Information
11.5.2 Ceva Description, Business Overview and Total Revenue
11.5.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ceva Animal Biological Vaccine Products Offered
11.5.5 Ceva Recent Development
11.6 CAHIC
11.6.1 CAHIC Corporation Information
11.6.2 CAHIC Description, Business Overview and Total Revenue
11.6.3 CAHIC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 CAHIC Animal Biological Vaccine Products Offered
11.6.5 CAHIC Recent Development
11.7 HVRI
11.7.1 HVRI Corporation Information
11.7.2 HVRI Description, Business Overview and Total Revenue
11.7.3 HVRI Sales, Revenue and Gross Margin (2015-2020)
11.7.4 HVRI Animal Biological Vaccine Products Offered
11.7.5 HVRI Recent Development
11.8 Ringpu Biology
11.8.1 Ringpu Biology Corporation Information
11.8.2 Ringpu Biology Description, Business Overview and Total Revenue
11.8.3 Ringpu Biology Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ringpu Biology Animal Biological Vaccine Products Offered
11.8.5 Ringpu Biology Recent Development
11.9 Yebio
11.9.1 Yebio Corporation Information
11.9.2 Yebio Description, Business Overview and Total Revenue
11.9.3 Yebio Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Yebio Animal Biological Vaccine Products Offered
11.9.5 Yebio Recent Development
11.10 DHN
11.10.1 DHN Corporation Information
11.10.2 DHN Description, Business Overview and Total Revenue
11.10.3 DHN Sales, Revenue and Gross Margin (2015-2020)
11.10.4 DHN Animal Biological Vaccine Products Offered
11.10.5 DHN Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Animal Biological Vaccine Products Offered
11.1.5 Merck Recent Development
11.12 Elanco/Eli Lilly
11.12.1 Elanco/Eli Lilly Corporation Information
11.12.2 Elanco/Eli Lilly Description, Business Overview and Total Revenue
11.12.3 Elanco/Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Elanco/Eli Lilly Products Offered
11.12.5 Elanco/Eli Lilly Recent Development
11.13 Virbac
11.13.1 Virbac Corporation Information
11.13.2 Virbac Description, Business Overview and Total Revenue
11.13.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Virbac Products Offered
11.13.5 Virbac Recent Development
11.14 Jinyu Bio-Technology
11.14.1 Jinyu Bio-Technology Corporation Information
11.14.2 Jinyu Bio-Technology Description, Business Overview and Total Revenue
11.14.3 Jinyu Bio-Technology Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Jinyu Bio-Technology Products Offered
11.14.5 Jinyu Bio-Technology Recent Development
11.15 ChengDu Tecbond
11.15.1 ChengDu Tecbond Corporation Information
11.15.2 ChengDu Tecbond Description, Business Overview and Total Revenue
11.15.3 ChengDu Tecbond Sales, Revenue and Gross Margin (2015-2020)
11.15.4 ChengDu Tecbond Products Offered
11.15.5 ChengDu Tecbond Recent Development
11.16 CAVAC
11.16.1 CAVAC Corporation Information
11.16.2 CAVAC Description, Business Overview and Total Revenue
11.16.3 CAVAC Sales, Revenue and Gross Margin (2015-2020)
11.16.4 CAVAC Products Offered
11.16.5 CAVAC Recent Development
11.17 Kyoto Biken
11.17.1 Kyoto Biken Corporation Information
11.17.2 Kyoto Biken Description, Business Overview and Total Revenue
11.17.3 Kyoto Biken Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Kyoto Biken Products Offered
11.17.5 Kyoto Biken Recent Development
11.18 FATRO
11.18.1 FATRO Corporation Information
11.18.2 FATRO Description, Business Overview and Total Revenue
11.18.3 FATRO Sales, Revenue and Gross Margin (2015-2020)
11.18.4 FATRO Products Offered
11.18.5 FATRO Recent Development
11.19 Vaksindo
11.19.1 Vaksindo Corporation Information
11.19.2 Vaksindo Description, Business Overview and Total Revenue
11.19.3 Vaksindo Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Vaksindo Products Offered
11.19.5 Vaksindo Recent Development
11.20 Bio-Labs
11.20.1 Bio-Labs Corporation Information
11.20.2 Bio-Labs Description, Business Overview and Total Revenue
11.20.3 Bio-Labs Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Bio-Labs Products Offered
11.20.5 Bio-Labs Recent Development
11.21 Avimex Animal
11.21.1 Avimex Animal Corporation Information
11.21.2 Avimex Animal Description, Business Overview and Total Revenue
11.21.3 Avimex Animal Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Avimex Animal Products Offered
11.21.5 Avimex Animal Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Animal Biological Vaccine Market Estimates and Projections by Region
12.1.1 Global Animal Biological Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Animal Biological Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Animal Biological Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Animal Biological Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Animal Biological Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Animal Biological Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Animal Biological Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Animal Biological Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Animal Biological Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Animal Biological Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Animal Biological Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Animal Biological Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Animal Biological Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Animal Biological Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Animal Biological Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Animal Biological Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Animal Biological Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Animal Biological Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Animal Biological Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Animal Biological Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Animal Biological Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables

Table 1. Animal Biological Vaccine Market Segments

Table 2. Ranking of Global Top Animal Biological Vaccine Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Animal Biological Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)

Table 4. Major Manufacturers of Oral

Table 5. Major Manufacturers of Subcutaneous

Table 6. Major Manufacturers of Intramuscular

Table 7. Major Manufacturers of Others

Table 8. COVID-19 Impact Global Market: (Four Animal Biological Vaccine Market Size Forecast Scenarios)

Table 9. Opportunities and Trends for Animal Biological Vaccine Players in the COVID-19 Landscape

Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 11. Key Regions/Countries Measures against Covid-19 Impact

Table 12. Proposal for Animal Biological Vaccine Players to Combat Covid-19 Impact

Table 13. Global Animal Biological Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)

Table 14. Global Animal Biological Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026

Table 15. Global Animal Biological Vaccine Sales by Regions 2015-2020 (K Doses)

Table 16. Global Animal Biological Vaccine Sales Market Share by Regions (2015-2020)

Table 17. Global Animal Biological Vaccine Revenue by Regions 2015-2020 (US$ Million)

Table 18. Global Animal Biological Vaccine Sales by Manufacturers (2015-2020) (K Doses)

Table 19. Global Animal Biological Vaccine Sales Share by Manufacturers (2015-2020)

Table 20. Global Animal Biological Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 21. Global Animal Biological Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Biological Vaccine as of 2019)

Table 22. Animal Biological Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)

Table 23. Animal Biological Vaccine Revenue Share by Manufacturers (2015-2020)

Table 24. Key Manufacturers Animal Biological Vaccine Price (2015-2020) (USD/Dose)

Table 25. Animal Biological Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 26. Manufacturers Animal Biological Vaccine Product Type

Table 27. Date of International Manufacturers Enter into Animal Biological Vaccine Market

Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 29. Global Animal Biological Vaccine Sales by Type (2015-2020) (K Doses)

Table 30. Global Animal Biological Vaccine Sales Share by Type (2015-2020)

Table 31. Global Animal Biological Vaccine Revenue by Type (2015-2020) (US$ Million)

Table 32. Global Animal Biological Vaccine Revenue Share by Type (2015-2020)

Table 33. Animal Biological Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)

Table 34. Global Animal Biological Vaccine Sales by Application (2015-2020) (K Doses)

Table 35. Global Animal Biological Vaccine Sales Share by Application (2015-2020)

Table 36. North America Animal Biological Vaccine Sales by Country (2015-2020) (K Doses)

Table 37. North America Animal Biological Vaccine Sales Market Share by Country (2015-2020)

Table 38. North America Animal Biological Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 39. North America Animal Biological Vaccine Revenue Market Share by Country (2015-2020)

Table 40. North America Animal Biological Vaccine Sales by Type (2015-2020) (K Doses)

Table 41. North America Animal Biological Vaccine Sales Market Share by Type (2015-2020)

Table 42. North America Animal Biological Vaccine Sales by Application (2015-2020) (K Doses)

Table 43. North America Animal Biological Vaccine Sales Market Share by Application (2015-2020)

Table 44. Europe Animal Biological Vaccine Sales by Country (2015-2020) (K Doses)

Table 45. Europe Animal Biological Vaccine Sales Market Share by Country (2015-2020)

Table 46. Europe Animal Biological Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 47. Europe Animal Biological Vaccine Revenue Market Share by Country (2015-2020)

Table 48. Europe Animal Biological Vaccine Sales by Type (2015-2020) (K Doses)

Table 49. Europe Animal Biological Vaccine Sales Market Share by Type (2015-2020)

Table 50. Europe Animal Biological Vaccine Sales by Application (2015-2020) (K Doses)

Table 51. Europe Animal Biological Vaccine Sales Market Share by Application (2015-2020)

Table 52. Asia Pacific Animal Biological Vaccine Sales by Region (2015-2020) (K Doses)

Table 53. Asia Pacific Animal Biological Vaccine Sales Market Share by Region (2015-2020)

Table 54. Asia Pacific Animal Biological Vaccine Revenue by Region (2015-2020) (US$ Million)

Table 55. Asia Pacific Animal Biological Vaccine Revenue Market Share by Region (2015-2020)

Table 56. Asia Pacific Animal Biological Vaccine Sales by Type (2015-2020) (K Doses)

Table 57. Asia Pacific Animal Biological Vaccine Sales Market Share by Type (2015-2020)

Table 58. Asia Pacific Animal Biological Vaccine Sales by Application (2015-2020) (K Doses)

Table 59. Asia Pacific Animal Biological Vaccine Sales Market Share by Application (2015-2020)

Table 60. Latin America Animal Biological Vaccine Sales by Country (2015-2020) (K Doses)

Table 61. Latin America Animal Biological Vaccine Sales Market Share by Country (2015-2020)

Table 62. Latin Americaa Animal Biological Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 63. Latin America Animal Biological Vaccine Revenue Market Share by Country (2015-2020)

Table 64. Latin America Animal Biological Vaccine Sales by Type (2015-2020) (K Doses)

Table 65. Latin America Animal Biological Vaccine Sales Market Share by Type (2015-2020)

Table 66. Latin America Animal Biological Vaccine Sales by Application (2015-2020) (K Doses)

Table 67. Latin America Animal Biological Vaccine Sales Market Share by Application (2015-2020)

Table 68. Middle East and Africa Animal Biological Vaccine Sales by Country (2015-2020) (K Doses)

Table 69. Middle East and Africa Animal Biological Vaccine Sales Market Share by Country (2015-2020)

Table 70. Middle East and Africa Animal Biological Vaccine Revenue by Country (2015-2020) (US$ Million)

Table 71. Middle East and Africa Animal Biological Vaccine Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Animal Biological Vaccine Sales by Type (2015-2020) (K Doses)

Table 73. Middle East and Africa Animal Biological Vaccine Sales Market Share by Type (2015-2020)

Table 74. Middle East and Africa Animal Biological Vaccine Sales by Application (2015-2020) (K Doses)

Table 75. Middle East and Africa Animal Biological Vaccine Sales Market Share by Application (2015-2020)

Table 76. Merck Corporation Information

Table 77. Merck Description and Major Businesses

Table 78. Merck Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 79. Merck Product

Table 80. Merck Recent Development

Table 81. Zoetis Corporation Information

Table 82. Zoetis Description and Major Businesses

Table 83. Zoetis Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 84. Zoetis Product

Table 85. Zoetis Recent Development

Table 86. Merial/Sanofi Corporation Information

Table 87. Merial/Sanofi Description and Major Businesses

Table 88. Merial/Sanofi Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 89. Merial/Sanofi Product

Table 90. Merial/Sanofi Recent Development

Table 91. Boehringer Ingelheim Corporation Information

Table 92. Boehringer Ingelheim Description and Major Businesses

Table 93. Boehringer Ingelheim Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 94. Boehringer Ingelheim Product

Table 95. Boehringer Ingelheim Recent Development

Table 96. Ceva Corporation Information

Table 97. Ceva Description and Major Businesses

Table 98. Ceva Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 99. Ceva Product

Table 100. Ceva Recent Development

Table 101. CAHIC Corporation Information

Table 102. CAHIC Description and Major Businesses

Table 103. CAHIC Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 104. CAHIC Product

Table 105. CAHIC Recent Development

Table 106. HVRI Corporation Information

Table 107. HVRI Description and Major Businesses

Table 108. HVRI Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 109. HVRI Product

Table 110. HVRI Recent Development

Table 111. Ringpu Biology Corporation Information

Table 112. Ringpu Biology Description and Major Businesses

Table 113. Ringpu Biology Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 114. Ringpu Biology Product

Table 115. Ringpu Biology Recent Development

Table 116. Yebio Corporation Information

Table 117. Yebio Description and Major Businesses

Table 118. Yebio Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 119. Yebio Product

Table 120. Yebio Recent Development

Table 121. DHN Corporation Information

Table 122. DHN Description and Major Businesses

Table 123. DHN Animal Biological Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 124. DHN Product

Table 125. DHN Recent Development

Table 126. WINSUN Corporation Information

Table 127. WINSUN Description and Major Businesses

Table 128. WINSUN Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 129. WINSUN Product

Table 130. WINSUN Recent Development

Table 131. Elanco/Eli Lilly Corporation Information

Table 132. Elanco/Eli Lilly Description and Major Businesses

Table 133. Elanco/Eli Lilly Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 134. Elanco/Eli Lilly Product

Table 135. Elanco/Eli Lilly Recent Development

Table 136. Virbac Corporation Information

Table 137. Virbac Description and Major Businesses

Table 138. Virbac Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 139. Virbac Product

Table 140. Virbac Recent Development

Table 141. Jinyu Bio-Technology Corporation Information

Table 142. Jinyu Bio-Technology Description and Major Businesses

Table 143. Jinyu Bio-Technology Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 144. Jinyu Bio-Technology Product

Table 145. Jinyu Bio-Technology Recent Development

Table 146. ChengDu Tecbond Corporation Information

Table 147. ChengDu Tecbond Description and Major Businesses

Table 148. ChengDu Tecbond Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 149. ChengDu Tecbond Product

Table 150. ChengDu Tecbond Recent Development

Table 151. CAVAC Corporation Information

Table 152. CAVAC Description and Major Businesses

Table 153. CAVAC Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 154. CAVAC Product

Table 155. CAVAC Recent Development

Table 156. Kyoto Biken Corporation Information

Table 157. Kyoto Biken Description and Major Businesses

Table 158. Kyoto Biken Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 159. Kyoto Biken Product

Table 160. Kyoto Biken Recent Development

Table 161. FATRO Corporation Information

Table 162. FATRO Description and Major Businesses

Table 163. FATRO Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 164. FATRO Product

Table 165. FATRO Recent Development

Table 166. Vaksindo Corporation Information

Table 167. Vaksindo Description and Major Businesses

Table 168. Vaksindo Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 169. Vaksindo Product

Table 170. Vaksindo Recent Development

Table 171. Bio-Labs Corporation Information

Table 172. Bio-Labs Description and Major Businesses

Table 173. Bio-Labs Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 174. Bio-Labs Product

Table 175. Bio-Labs Recent Development

Table 176. Avimex Animal Corporation Information

Table 177. Avimex Animal Description and Major Businesses

Table 178. Avimex Animal Animal Biological Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 179. Avimex Animal Product

Table 180. Avimex Animal Recent Development

Table 181. Global Animal Biological Vaccine Sales Forecast by Regions (2021-2026) (K Doses)

Table 182. Global Animal Biological Vaccine Sales Market Share Forecast by Regions (2021-2026)

Table 183. Global Animal Biological Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 184. Global Animal Biological Vaccine Revenue Market Share Forecast by Regions (2021-2026)

Table 185. North America: Animal Biological Vaccine Sales Forecast by Country (2021-2026) (K Doses)

Table 186. North America: Animal Biological Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 187. Europe: Animal Biological Vaccine Sales Forecast by Country (2021-2026) (K Doses)

Table 188. Europe: Animal Biological Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 189. Asia Pacific: Animal Biological Vaccine Sales Forecast by Region (2021-2026) (K Doses)

Table 190. Asia Pacific: Animal Biological Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)

Table 191. Latin America: Animal Biological Vaccine Sales Forecast by Country (2021-2026) (K Doses)

Table 192. Latin America: Animal Biological Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 193. Middle East and Africa: Animal Biological Vaccine Sales Forecast by Country (2021-2026) (K Doses)

Table 194. Middle East and Africa: Animal Biological Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)

Table 195. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 196. Key Challenges

Table 197. Market Risks

Table 198. Main Points Interviewed from Key Animal Biological Vaccine Players

Table 199. Animal Biological Vaccine Customers List

Table 200. Animal Biological Vaccine Distributors List

Table 201. Research Programs/Design for This Report

Table 202. Key Data Information from Secondary Sources

Table 203. Key Data Information from Primary Sources

List of Figures

Figure 1. Animal Biological Vaccine Product Picture

Figure 2. Global Animal Biological Vaccine Sales Market Share by Type in 2020 & 2026

Figure 3. Oral Product Picture

Figure 4. Subcutaneous Product Picture

Figure 5. Intramuscular Product Picture

Figure 6. Others Product Picture

Figure 7. Global Animal Biological Vaccine Sales Market Share by Application in 2020 & 2026

Figure 8. Porcine

Figure 9. Poultry

Figure 10. Livestock

Figure 11. Companion Animals

Figure 12. Aquaculture

Figure 13. Animal Biological Vaccine Report Years Considered

Figure 14. Global Animal Biological Vaccine Market Size 2015-2026 (US$ Million)

Figure 15. Global Animal Biological Vaccine Sales 2015-2026 (K Doses)

Figure 16. Global Animal Biological Vaccine Market Size Market Share by Region: 2020 Versus 2026

Figure 17. Global Animal Biological Vaccine Sales Market Share by Region (2015-2020)

Figure 18. Global Animal Biological Vaccine Sales Market Share by Region in 2019

Figure 19. Global Animal Biological Vaccine Revenue Market Share by Region (2015-2020)

Figure 20. Global Animal Biological Vaccine Revenue Market Share by Region in 2019

Figure 21. Global Animal Biological Vaccine Sales Share by Manufacturer in 2019

Figure 22. The Top 10 and 5 Players Market Share by Animal Biological Vaccine Revenue in 2019

Figure 23. Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 24. Global Animal Biological Vaccine Sales Market Share by Type (2015-2020)

Figure 25. Global Animal Biological Vaccine Sales Market Share by Type in 2019

Figure 26. Global Animal Biological Vaccine Revenue Market Share by Type (2015-2020)

Figure 27. Global Animal Biological Vaccine Revenue Market Share by Type in 2019

Figure 28. Global Animal Biological Vaccine Market Share by Price Range (2015-2020)

Figure 29. Global Animal Biological Vaccine Sales Market Share by Application (2015-2020)

Figure 30. Global Animal Biological Vaccine Sales Market Share by Application in 2019

Figure 31. Global Animal Biological Vaccine Revenue Market Share by Application (2015-2020)

Figure 32. Global Animal Biological Vaccine Revenue Market Share by Application in 2019

Figure 33. North America Animal Biological Vaccine Sales Growth Rate 2015-2020 (K Doses)

Figure 34. North America Animal Biological Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 35. North America Animal Biological Vaccine Sales Market Share by Country in 2019

Figure 36. North America Animal Biological Vaccine Revenue Market Share by Country in 2019

Figure 37. U.S. Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 38. U.S. Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 39. Canada Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 40. Canada Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 41. North America Animal Biological Vaccine Market Share by Type in 2019

Figure 42. North America Animal Biological Vaccine Market Share by Application in 2019

Figure 43. Europe Animal Biological Vaccine Sales Growth Rate 2015-2020 (K Doses)

Figure 44. Europe Animal Biological Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 45. Europe Animal Biological Vaccine Sales Market Share by Country in 2019

Figure 46. Europe Animal Biological Vaccine Revenue Market Share by Country in 2019

Figure 47. Germany Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 48. Germany Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 49. France Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 50. France Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. U.K. Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 52. U.K. Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. Italy Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 54. Italy Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Russia Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 56. Russia Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Europe Animal Biological Vaccine Market Share by Type in 2019

Figure 58. Europe Animal Biological Vaccine Market Share by Application in 2019

Figure 59. Asia Pacific Animal Biological Vaccine Sales Growth Rate 2015-2020 (K Doses)

Figure 60. Asia Pacific Animal Biological Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 61. Asia Pacific Animal Biological Vaccine Sales Market Share by Region in 2019

Figure 62. Asia Pacific Animal Biological Vaccine Revenue Market Share by Region in 2019

Figure 63. China Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 64. China Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. Japan Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 66. Japan Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. South Korea Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 68. South Korea Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. India Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 70. India Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. Australia Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 72. Australia Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Taiwan Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 74. Taiwan Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Indonesia Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 76. Indonesia Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Thailand Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 78. Thailand Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Malaysia Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 80. Malaysia Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Philippines Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 82. Philippines Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Vietnam Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 84. Vietnam Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Asia Pacific Animal Biological Vaccine Market Share by Type in 2019

Figure 86. Asia Pacific Animal Biological Vaccine Market Share by Application in 2019

Figure 87. Latin America Animal Biological Vaccine Sales Growth Rate 2015-2020 (K Doses)

Figure 88. Latin America Animal Biological Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 89. Latin America Animal Biological Vaccine Sales Market Share by Country in 2019

Figure 90. Latin America Animal Biological Vaccine Revenue Market Share by Country in 2019

Figure 91. Mexico Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 92. Mexico Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Brazil Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 94. Brazil Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Argentina Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 96. Argentina Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Latin America Animal Biological Vaccine Market Share by Type in 2019

Figure 98. Latin America Animal Biological Vaccine Market Share by Application in 2019

Figure 99. Middle East and Africa Animal Biological Vaccine Sales Growth Rate 2015-2020 (K Doses)

Figure 100. Middle East and Africa Animal Biological Vaccine Revenue Growth Rate 2015-2020 (US$ Million)

Figure 101. Middle East and Africa Animal Biological Vaccine Sales Market Share by Country in 2019

Figure 102. Middle East and Africa Animal Biological Vaccine Revenue Market Share by Country in 2019

Figure 103. Turkey Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 104. Turkey Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. Saudi Arabia Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 106. Saudi Arabia Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. U.A.E Animal Biological Vaccine Sales Growth Rate (2015-2020) (K Doses)

Figure 108. U.A.E Animal Biological Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

Figure 109. Middle East and Africa Animal Biological Vaccine Market Share by Type in 2019

Figure 110. Middle East and Africa Animal Biological Vaccine Market Share by Application in 2019

Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018

Figure 112. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 113. Merial/Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 114. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018

Figure 115. Ceva Total Revenue (US$ Million): 2019 Compared with 2018

Figure 116. CAHIC Total Revenue (US$ Million): 2019 Compared with 2018

Figure 117. HVRI Total Revenue (US$ Million): 2019 Compared with 2018

Figure 118. Ringpu Biology Total Revenue (US$ Million): 2019 Compared with 2018

Figure 119. Yebio Total Revenue (US$ Million): 2019 Compared with 2018

Figure 120. DHN Total Revenue (US$ Million): 2019 Compared with 2018

Figure 121. WINSUN Total Revenue (US$ Million): 2019 Compared with 2018

Figure 122. Elanco/Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 123. Virbac Total Revenue (US$ Million): 2019 Compared with 2018

Figure 124. Jinyu Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018

Figure 125. ChengDu Tecbond Total Revenue (US$ Million): 2019 Compared with 2018

Figure 126. CAVAC Total Revenue (US$ Million): 2019 Compared with 2018

Figure 127. Kyoto Biken Total Revenue (US$ Million): 2019 Compared with 2018

Figure 128. FATRO Total Revenue (US$ Million): 2019 Compared with 2018

Figure 129. Vaksindo Total Revenue (US$ Million): 2019 Compared with 2018

Figure 130. Bio-Labs Total Revenue (US$ Million): 2019 Compared with 2018

Figure 131. Avimex Animal Total Revenue (US$ Million): 2019 Compared with 2018

Figure 132. North America Animal Biological Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)

Figure 133. North America Animal Biological Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 134. Europe Animal Biological Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)

Figure 135. Europe Animal Biological Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 136. Asia Pacific Animal Biological Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)

Figure 137. Asia Pacific Animal Biological Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 138. Latin America Animal Biological Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)

Figure 139. Latin America Animal Biological Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 140. Middle East and Africa Animal Biological Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)

Figure 141. Middle East and Africa Animal Biological Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 142. Porter's Five Forces Analysis

Figure 143. Channels of Distribution

Figure 144. Distributors Profiles

Figure 145. Bottom-up and Top-down Approaches for This Report

Figure 146. Data Triangulation

Figure 147. Key Executives Interviewed

Merck

Zoetis

Merial/Sanofi

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco/Eli Lilly

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken

FATRO

Vaksindo

Bio-Labs

Avimex Animal

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3237

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase